Advertisement

Tumor Biology

, Volume 35, Issue 6, pp 5111–5119 | Cite as

Anti-tumor activities of matrine and oxymatrine: literature review

  • Yan Liu
  • Yang Xu
  • Weidan Ji
  • Xiaoya Li
  • Bin Sun
  • Quangen GaoEmail author
  • Changqing SuEmail author
Review

Abstract

Matrine (MT) and oxymatrine (OMT), two kinds of alkaloid components found in the roots of Sophora species, have various pharmacological activities and are demonstrated to have anti-inflammatory, anti-allergic, anti-virus, anti-fibrotic, and cardiovascular protective effects. They are recently proved to have anti-cancer potentials, such as inhibiting cancer cell proliferation, inducing cell cycle arrest, accelerating apoptosis, restraining angiogenesis, inducing cell differentiation, inhibiting cancer metastasis and invasion, reversing multidrug resistance, and preventing or reducing chemotherapy- or radiotherapy-induced toxicity when combined with other chemotherapeutic drugs. In this review, we summarize the recent investigations regarding the anti-cancer activities and possible molecular targets of MT and OMT for cancer prevention and treatment in order to provide clues and references for further study.

Keywords

Matrine Oxymatrine Anticancer activity Molecular mechanism 

Notes

Acknowledgments

This work was supported by grants from the Plan Project of Shanghai Outstanding Academic Leaders (13XD1400300), the National Significant Science and Technology Special Projects of New Drugs Creation (2014ZX09101003), and the National Natural Science Foundation of China (81370552, 81372472).

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Cai XZ, Huang WY, Qiao Y, Du SY, Chen Y, Chen D, et al. Inhibitory effects of curcumin on gastric cancer cells: a proteomic study of molecular targets. Phytomedicine. 2013;20:495–505.CrossRefPubMedGoogle Scholar
  2. 2.
    Bishayee A, Politis T, Darvesh AS. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat Rev. 2010;36:43–53.CrossRefPubMedGoogle Scholar
  3. 3.
    Liu TY, Tan ZJ, Jiang L, Gu JF, Wu XS, Cao Y, et al. Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells. Cancer Cell Int. 2013;13(1):64.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Wang S, Yu S, Shi W, Ge L, Yu X, Fan J, et al. Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling. IUBMB Life. 2011;63(9):775–82.PubMedGoogle Scholar
  5. 5.
    Saleem M, Murtaza I, Tarapore RS, Suh Y, Adhami VM, Johnson JJ, et al. Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling. Carcinogenesis. 2009;30(5):808–17.PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Saleem M, Maddodi N, Abu Zaid M, Khan N, bin Hafeez B, Asim M, et al. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clin Cancer Res. 2008;14(7):2119–27.CrossRefPubMedGoogle Scholar
  7. 7.
    Funaya N, Haginaka J. Matrine- and oxymatrine-imprinted monodisperse polymers prepared by precipitation polymerization and their applications for the selective extraction of matrine-type alkaloids from Sophora flavescens Aiton. J Chromatogr A. 2012;1248:18–23.CrossRefPubMedGoogle Scholar
  8. 8.
    Lai JP, He XW, Jiang Y, Chen F. Preparative separation and determination of matrine from the Chinese medicinal plant Sophora flavescens Ait by molecularly imprinted solid-phase extraction. Anal Bioanal Chem. 2003;375:264–9.PubMedGoogle Scholar
  9. 9.
    Liu JY, Hu JH, Zhu QG, Li FQ, Wang J, Sun HJ. Effect of matrine on the expression of substance P receptor and inflammatory cytokines production in human skin keratinocytes and fibroblasts. Int Immunopharmacol. 2007;7:816–23.CrossRefPubMedGoogle Scholar
  10. 10.
    Sun J, Mao J, Liu X, Wang Y, Sun Y, He Z. Separation and mechanism elucidation for six structure-like matrine-type alkaloids by micellar liquid chromatography. J Sep Sci. 2009;32:2043–50.CrossRefPubMedGoogle Scholar
  11. 11.
    Guzman JR, Koo JS, Goldsmith JR, Muhlbauer M, Narula A, Jobin C. Oxymatrine prevents NF-kappaB nuclear translocation and ameliorates acute intestinal inflammation. Sci Rep. 2013;3:1629.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Cao YG, Jing S, Li L, Gao JQ, Shen ZY, Liu Y, et al. Antiarrhythmic effects and ionic mechanisms of oxymatrine from Sophora flavescens. Phytother Res. 2010;24:1844–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Yang Y, Xiu J, Zhang X, Zhang L, Yan K, Qin C, et al. Antiviral effect of matrine against human enterovirus 71. Molecules. 2012;17:10370–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Chai NL, Fu Q, Shi H, Cai CH, Wan J, Xu SP, et al. Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells. World J Gastroenterol. 2012;18:4199–206.PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Li XM, Brown L. Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy. J Allergy Clin Immunol. 2009;123:297–306. quiz 7-8.PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Liu H, Sun Y, Gao Y, Chen F, Xu M, Liu Z. The analgesic effect and mechanism of the combination of sodium ferulate and oxymatrine. Neurochem Res. 2010;35:1368–75.CrossRefPubMedGoogle Scholar
  17. 17.
    Kan QC, Zhu L, Liu N, Zhang GX. Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity. Immunol Res. 2013;56:189–96.CrossRefPubMedGoogle Scholar
  18. 18.
    Zhang J, Li Y, Chen X, Liu T, Chen Y, He W, et al. Autophagy is involved in anticancer effects of matrine on SGC-7901 human gastric cancer cells. Oncol Rep. 2011;26:115–24.PubMedGoogle Scholar
  19. 19.
    Zhang Y, Zhang H, Yu P, Liu Q, Liu K, Duan H, et al. Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology. 2009;59:191–200.PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Li LQ, Li XL, Wang L, Du WJ, Guo R, Liang HH, et al. Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells. Cell Physiol Biochem. 2012;30:631–41.CrossRefPubMedGoogle Scholar
  21. 21.
    Zhang JQ, Li YM, Liu T, He WT, Chen YT, Chen XH, et al. Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy. World J Gastroenterol. 2010;16:4281–90.PubMedCentralCrossRefPubMedGoogle Scholar
  22. 22.
    Chen H, Zhang J, Luo J, Lai F, Wang Z, Tong H, et al. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-kappaB-mediated VEGF signaling pathway. Oncol Rep. 2013;30:589–95.PubMedGoogle Scholar
  23. 23.
    Jin H, Sun Y, Wang S, Cheng X. Matrine activates PTEN to induce growth inhibition and apoptosis in V600EBRAF harboring melanoma cells. Int J Mol Sci. 2013;14:16040–57.PubMedCentralCrossRefPubMedGoogle Scholar
  24. 24.
    Zhang S, Zhang Y, Zhuang Y, Wang J, Ye J, Zhang S, et al. Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation. PloS One. 2012;7:e46853.PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    Zhang L, Wang T, Wen X, Wei Y, Peng X, Li H, et al. Effect of matrine on HeLa cell adhesion and migration. Eur J Pharmacol. 2007;563:69–76.CrossRefPubMedGoogle Scholar
  26. 26.
    Yan F, Liu Y, Wang W. Matrine inhibited the growth of rat osteosarcoma UMR-108 cells by inducing apoptosis in a mitochondrial-caspase-dependent pathway. Tumour Biol. 2013;34:2135–40.CrossRefPubMedGoogle Scholar
  27. 27.
    Ramasamy K, Agarwal R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 2008;269:352–62.PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ, Tao HM. Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother Pharmacol. 2012;69:317–31.CrossRefPubMedGoogle Scholar
  29. 29.
    Zhao B, Li B, Bai S, Shen L, Ren R, Jonas JB, et al. Effects of matrine on proliferation and apoptosis of cultured retinoblastoma cells. Graefes Arch Clin Exp Ophthalmol. 2012;250:897–905.CrossRefPubMedGoogle Scholar
  30. 30.
    Xing Y, Yan F, Liu Y, Liu Y, Zhao Y. Matrine inhibits 3 T3-L1 preadipocyte differentiation associated with suppression of ERK1/2 phosphorylation. Biochem Biophys Res Commun. 2010;396:691–5.CrossRefPubMedGoogle Scholar
  31. 31.
    Yu HB, Zhang HF, Li DY, Zhang X, Xue HZ, Zhao SH. Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. J Asian Nat Prod Res. 2011;13:242–50.CrossRefPubMedGoogle Scholar
  32. 32.
    Wang YP, Zhao W, Xue R, Zhou ZX, Liu F, Han YX, et al. Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance. Antiviral Res. 2011;89:227–31.CrossRefPubMedGoogle Scholar
  33. 33.
    Sun Q, Ma W, Gao Y, Zheng W, Zhang B, Peng Y. Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma. Afr J Tradit Complement Altern Med. 2012;9:178–88.PubMedCentralPubMedGoogle Scholar
  34. 34.
    Luo C, Zhu Y, Jiang T, Lu X, Zhang W, Jing Q, et al. Matrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 family. Toxicology. 2007;229:245–52.CrossRefPubMedGoogle Scholar
  35. 35.
    Dai ZJ, Gao J, Ji ZZ, Wang XJ, Ren HT, Liu XX, et al. Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3. J Ethnopharmacol. 2009;123:91–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Yu P, Liu Q, Liu K, Yagasaki K, Wu E, Zhang G. Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology. 2009;59:219–29.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    Song G, Luo Q, Qin J, Wang L, Shi Y, Sun C. Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells. Colloids Surf B: Biointerfaces. 2006;48:1–5.CrossRefPubMedGoogle Scholar
  38. 38.
    Zou J, Ran ZH, Xu Q, Xiao SD. Experimental study of the killing effects of oxymatrine on human colon cancer cell line SW1116. Chin J Dig Dis. 2005;6:15–20.CrossRefPubMedGoogle Scholar
  39. 39.
    Zhang S, Qi J, Sun L, Cheng B, Pan S, Zhou M, et al. Matrine induces programmed cell death and regulates expression of relevant genes based on PCR array analysis in C6 glioma cells. Mol Biol Rep. 2009;36:791–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Ling Q, Xu X, Wei X, Wang W, Zhou B, Wang B, et al. Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. J Exp Clin Cancer Res. 2011;30:66.PubMedCentralCrossRefPubMedGoogle Scholar
  41. 41.
    Liu XS, Jiang JK, Jiao XY, Wu YE, Lin JH. Matrine-induced apoptosis in leukemia U937 cells-involvement of caspases activation and MAPK-independent pathways. Planta Med. 2006;72:501–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Liu TY, Song Y, Chen H, Pan SH, Sun XY. Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo. Biol Pharm Bull. 2010;33:1740–5.CrossRefPubMedGoogle Scholar
  43. 43.
    Ma L, Wen S, Zhan Y, He Y, Liu X, Jiang J. Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med. 2008;74:245–51.CrossRefPubMedGoogle Scholar
  44. 44.
    Wang L, You Y, Wang S, Liu X, Liu B, Wang J, et al. Synthesis, characterization and in vitro anti-tumor activities of matrine derivatives. Bioorg Med Chem Lett. 2012;22(12):4100–2.CrossRefPubMedGoogle Scholar
  45. 45.
    Shi C, Yu L, Yang F, Yan J, Zeng H. A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines. Biochem Biophys Res Commun. 2003;309:578–83.CrossRefPubMedGoogle Scholar
  46. 46.
    Zhao JF, Xie GR, Li XM, Chen WT, Sun ML, Fang Z, et al. Effect of Matrine on cell cycle and human telomerase reverse transcriptase of human salivary adenoid cystic carcinoma. Hua Xi Kou Qiang Yi Xue Za Zhi. 2010;28:234–40.PubMedGoogle Scholar
  47. 47.
    Zhang Z, Wang X, Wu W, Wang J, Wang Y, Wu X, et al. Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD). Phytother Res. 2012;26:932–7.CrossRefPubMedGoogle Scholar
  48. 48.
    Harbour JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 2000;14:2393–409.CrossRefPubMedGoogle Scholar
  49. 49.
    Jiang H, Hou C, Zhang S, Xie H, Zhou W, Jin Q, et al. Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells. Eur J Pharmacol. 2007;559:98–108.CrossRefPubMedGoogle Scholar
  50. 50.
    Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene. 2003;22:8543–67.CrossRefPubMedGoogle Scholar
  51. 51.
    Spencer SL, Sorger PK. Measuring and modeling apoptosis in single cells. Cell. 2011;144:926–39.PubMedCentralCrossRefPubMedGoogle Scholar
  52. 52.
    Zhang Y, Sun S, Chen J, Ren P, Hu Y, Cao Z, et al. Oxymatrine induces mitochondria dependent apoptosis in human osteosarcoma MNNG/HOS cells through inhibition of PI3K/Akt pathway. Tumour Biol. 2013. doi: 10.1007/s13277-013-1223-z.Google Scholar
  53. 53.
    Bröker LE, Kruyt FAE, Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res. 2005;11:3155–62.CrossRefPubMedGoogle Scholar
  54. 54.
    Zheng SY, Li DC, Zhang ZD, Zhao J, Ge JF. Adenovirus-mediated FasL gene transfer into human gastric carcinoma. World J Gastroenterol. 2005;11:3446–50.PubMedCentralCrossRefPubMedGoogle Scholar
  55. 55.
    Tan CH, Qian XQ, Jia RD, Wu M, Liang ZQ. Matrine induction of reactive oxygen species activates p38 leading to caspase-dependent cell apoptosis in non-small cell lung cancer cells. Oncol Rep. 2013;30:2529–35.PubMedGoogle Scholar
  56. 56.
    Song MQ, Zhu JS, Chen JL, Wang L, Da W, Zhu L, et al. Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells. World J Gastroenterol. 2007;13:1788–93.PubMedCentralCrossRefPubMedGoogle Scholar
  57. 57.
    Jin Y, Hu J, Wang Q, Li Z, Chen Y. Effects of oxymatrine on the apoptosis of human esophageal carcinoma Eca109 cell line and its mechanism. J Huazhong Univ of Sci Technolog Med Sci. 2008;28:314–6.CrossRefGoogle Scholar
  58. 58.
    Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78:2081–7.CrossRefPubMedGoogle Scholar
  59. 59.
    Lee TH, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK, et al. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. PLoS Med. 2007;4:e186.PubMedCentralCrossRefPubMedGoogle Scholar
  60. 60.
    North S, Moenner M, Bikfalvi A. Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors. Cancer Lett. 2005;218:1–14.CrossRefPubMedGoogle Scholar
  61. 61.
    Qu F, Cui YR, Xu J. Anttumor effects of matrine on murine hepatocarcinoma cell line H22 and the mechanism. Anti-tumor Pharmacy (China). 2011;1:374–8.Google Scholar
  62. 62.
    Hlobilkova A, Ehrmann J, Knizetova P, Krejci V, Kalita O, Kolar Z. Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression. Neoplasma. 2009;56:284–90.CrossRefPubMedGoogle Scholar
  63. 63.
    Park JH, Jeong YJ, Park KK, Cho HJ, Chung IK, Min KS, et al. Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Mol Cells. 2010;29:209–15.CrossRefPubMedGoogle Scholar
  64. 64.
    Liu XY, Fang H, Yang ZG, Wang XY, Ruan LM, Fang DR, et al. Matrine inhibits invasiveness and metastasis of human malignant melanoma cell line A375 in vitro. Int J Dermatol. 2008;47:448–56.CrossRefPubMedGoogle Scholar
  65. 65.
    Levy-Adam F, Ilan N, Vlodavsky I. Tumorigenic and adhesive properties of heparanase. Semin Cancer Biol. 2010;20:153–60.PubMedCentralCrossRefPubMedGoogle Scholar
  66. 66.
    Li H, Tan G, Jiang X, Qiao H, Pan S, Jiang H, et al. Therapeutic effects of matrine on primary and metastatic breast cancer. Am J Chin Med. 2010;38:1115–30.CrossRefPubMedGoogle Scholar
  67. 67.
    Kundu M, Thompson CB. Autophagy: basic principles and relevance to disease. Annu Rev Pathol. 2008;3:427–55.CrossRefPubMedGoogle Scholar
  68. 68.
    Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther. 2011;10:1533–41.PubMedCentralCrossRefPubMedGoogle Scholar
  69. 69.
    Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402:672–6.CrossRefPubMedGoogle Scholar
  70. 70.
    Wang Z, Zhang J, Wang Y, Xing R, Yi C, Zhu H, et al. Matrine, a novel autophagy inhibitor, blocks trafficking and the proteolytic activation of lysosomal proteases. Carcinogenesis. 2013;34:128–38.CrossRefPubMedGoogle Scholar
  71. 71.
    Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR. Protein composition of catalytically active human telomerase from immortal cells. Science. 2007;315:1850–3.CrossRefPubMedGoogle Scholar
  72. 72.
    Basu N, Skinner HG, Litzelman K, Vanderboom R, Baichoo E, Boardman LA. Telomeres and telomere dynamics: relevance to cancers of the GI tract. Expert Rev Gastroenterol Hepatol. 2013;7:733–48.PubMedCentralCrossRefPubMedGoogle Scholar
  73. 73.
    Liu HQ, Liu SL, Wang H, Xie XY, Chen XL, Zhang XM, et al. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer. Diagn Pathol. 2012;7:1–8.CrossRefGoogle Scholar
  74. 74.
    Zhang LP, Jiang JK, Tam JW, Zhang Y, Liu XS, Xu XR, et al. Effects of Matrine on proliferation and differentiation in K-562 cells. Leuk Res. 2001;25:793–800.CrossRefPubMedGoogle Scholar
  75. 75.
    Fukuchi Y, Yamato K, Kawamura C, Ikeda Y, Kizaki M. p27KIP1 and GATA-1 are potential downstream molecules in activin A-induced differentiation and apoptosis pathways in CML cells. Oncol Rep. 2006;16:1099–103.PubMedGoogle Scholar
  76. 76.
    Inoue N, Yahagi N, Yamamoto T, Ishikawa M, Watanabe K, Matsuzaka T, et al. Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance. J Biol Chem. 2008;283:21220–9.PubMedCentralCrossRefPubMedGoogle Scholar
  77. 77.
    He S, Liu F, Xie Z, Zu X, Xu W, Jiang Y. P-Glycoprotein/MDR1 regulates Pokemon gene transcription through p53 expression in human breast cancer cells. Int J Mol Sci. 2010;11:3309–51.PubMedCentralPubMedGoogle Scholar
  78. 78.
    Colabufo NA, Berardi F, Cantore M, Contino M, Inglese C, Niso M, et al. Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials. J Med Chem. 2010;53:1883–97.CrossRefPubMedGoogle Scholar
  79. 79.
    Chai S, To KK, Lin G. Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines. Chin Med. 2010;5:26.PubMedCentralCrossRefPubMedGoogle Scholar
  80. 80.
    Zhang J, Tang AZ. Reversal effect of matrine on drug resistance of human nasopharyngeal carcinoma cell line. Zhong Yao Cai. 2012;35(12):1989–94.PubMedGoogle Scholar
  81. 81.
    Liu F, Liu SY, He SN, Xie ZH, Zu XY, Jiang YY. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Oncol Rep. 2010;23:1469–75.CrossRefPubMedGoogle Scholar
  82. 82.
    Luo SX, Deng WY, Wang XF, Lu HF, Han LL, Chen BB, et al. Molecular mechanism of indirubin-3′-monoxime and matrine in the reversal of paclitaxel resistance in NCI-H520/TAX25 cell line. Chin Med J (Enql). 2013;126:925–9.Google Scholar
  83. 83.
    Gao HY, Li GY, Lou MM, Li XY, Wei XY, Wang JH. Hepatoprotective effect of matrine salvianolic acid B salt on carbon tetrachloride-induced hepatic fibrosis. J Inflamm (Lond). 2012;9:16.CrossRefGoogle Scholar
  84. 84.
    Hu ST, Tang Y, Shen YF, Ao HH, Bai J, Wang YL, et al. Protective effect of oxymatrine on chronic rat heart failure. J Physiol Sci. 2011;61:363–72.CrossRefPubMedGoogle Scholar
  85. 85.
    Xu W, Lin H, Zhang Y, Chen X, Hua B, Hou W, et al. Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/beta-catenin pathway. J Exp Clin Cancer Res. 2011;30:103.PubMedCentralCrossRefPubMedGoogle Scholar
  86. 86.
    Shao Q. The recent effect of radiotherapy combined with compound kushen injection for esophageal cancer. Radiother Oncol. 2011;99:S372–3.CrossRefGoogle Scholar
  87. 87.
    Lao Y. Clinical study on effect of matrine injection to protect the liver function for patients with primary hepatic carcinoma after trans-artery chemo-embolization (TAE). Zhong Yao Cai. 2005;28:637–8.PubMedGoogle Scholar
  88. 88.
    Zhang XL, Xu HR, Chen WL, Chu NN, Li XN, Liu GY, et al. Matrine determination and pharmacokinetics in human plasma using LC/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:3253–6.CrossRefPubMedGoogle Scholar
  89. 89.
    Yue PF, Yuan HL, Li XY, Yang M, Zhu WF. Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex. Int J Pharm. 2010;387:139–46.CrossRefPubMedGoogle Scholar
  90. 90.
    Ruan J, Liu J, Zhu D, Gong T, Yang F, Hao X, et al. Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique. Int J Pharm. 2010;386:282–90.CrossRefPubMedGoogle Scholar
  91. 91.
    Fan R, Liu R, Ma R, Bi K, Li Q. Determination of oxymatrine and its active metabolite matrine in human plasma after administration of oxymatrine oral solution by high-performance liquid chromatography coupled with mass spectrometry. Fitoterapia. 2013;89:271–7.CrossRefPubMedGoogle Scholar
  92. 92.
    Wu XL, Hang TJ, Shen JP, Zhang YD. Determination and pharmacokinetic study of oxymatrine and its metabolite matrine in human plasma by liquid chromatography tandem mass spectrometry. J Pharml Biomed Anal. 2006;41(3):918–24.CrossRefGoogle Scholar
  93. 93.
    Kennedy DA, Seely D. Clinically based evidence of drug-herb interactions: a systematic review. Expert Opin Drug Saf. 2010;9(1):79–124.CrossRefPubMedGoogle Scholar
  94. 94.
    Hu MJ, Zeng H, Wu YL, Zhang YP, Zhang S, Qiao MM, et al. Synergistic effects of matrine and 5-fluorouracil on tumor growth of the implanted gastric cancer in nude mice. Chin J Dig Dis. 2005;6(2):68–71.CrossRefPubMedGoogle Scholar
  95. 95.
    Yang CL, Liu SS, Ma YG, Liu YY, Xue YX, Huang B. The influence of intraoperative pleural perfusion with matrine-cisplatin or cisplatin on stromal cell-derived factor-1 in non-small cell lung cancer patients with subclinical pleural metastasis. Med Oncol. 2012;29(2):574–81.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  1. 1.Department of General SurgeryWujiang No.1 People’s HospitalSuzhouChina
  2. 2.Department of Molecular Oncology, Eastern Hepatobiliary Surgical HospitalSecond Military Medical UniversityShanghaiChina
  3. 3.Graduate SchoolXuzhou Medical CollegeXuzhouChina

Personalised recommendations